Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

Troglitazone

Troglitazone Structure
  • ₹18889.63
  • Product name: Troglitazone
  • CAS: 97322-87-7
  • MF: C24H27NO5S
  • MW: 441.54
  • EINECS:
  • MDL Number:MFCD00878416
  • Synonyms:Troglitazone(CS-045);RESULIN(TM);ROMGLIZONE;5-(4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2 ;ci991 ;enzopyran-2-yl)methoxy)phenyl)methyl)- ;gr92132x ;rezulin
1 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 5MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberT2573
  • Product descriptionTroglitazone ≥98% (HPLC)
  • Packaging5MG
  • Price₹18889.63
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) T2573 Troglitazone ≥98% (HPLC) 5MG ₹18889.63 2022-06-14 Buy

Properties

Melting point :184-186°C
Boiling point :657.0±55.0 °C(Predicted)
Density :1.266±0.06 g/cm3(Predicted)
storage temp. :Inert atmosphere,Store in freezer, under -20°C
solubility :DMSO: 20 mg/mL
form :solid
pka :6.34±0.50(Predicted)
color :white to yellow
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
InChIKey :GXPHKUHSUJUWKP-UHFFFAOYSA-N
CAS DataBase Reference :97322-87-7(CAS DataBase Reference)

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

Troglitazone is a TZD which was approved for the treatment of insulin resistance and hyperglycemia in Type II diabetes, under the trade name Resulin?, but was withdrawn from the market due to hepatotoxicity. Troglitazone is a potent and selective PPARγ agonist. The EC50 values for transactivation of human and mouse PPARγ in a cell-based assay are 0.55 and 0.78 μM, respectively. In the same assay system, no activation of PPARα and PPARδ was observed at concentrations up to 10 μM. Troglitazone binds to the PPARγ ligand-binding domain (LBD) but fails to induce interaction of the PPARγ LBD with the transcriptional coactivators SRC-1, TIF2, AIB1, p300, or TRAP220. Troglitazone also induces cell cycle arrest and apoptosis in several cancer cell lines with an EC50 of 10 μM.

Related product price